Kallikrein-related peptidase 4 (KLK4), a trypsin-like serine protease which is secreted by epithelial cells into their microenvironment [2,3,4], has been reported to have paradoxical effects in prostate cancer (PCa). Here, KLK4 is linked to prostate carcinoma.